Nested case-control study finds mixed effects of organophosphorus pesticides on diabetes risk and glucose levels.
Organophosphorus pesticides (OPs) are widely used in agriculture, but prospective studies on their chronic exposure and risk of type 2 diabetes (T2D) and glucose metabolism disorders are scarce. Most previous studies focused on agricultural workers and relied on questionnaires or urinary metabolites for exposure assessment. We conducted a nested case–control study with 1006 pairs of participants based on the Dongfeng–Tongji cohort to investigate the association between serum OP levels, T2D risk, and fasting blood glucose (FBG) changes over a 5-year follow-up. Serum OP concentrations were measured by gas chromatography–triple quadrupole mass spectrometry. Among the 29 types of OPs detected, Chlorpyrifos and Fenitrothion had detection rates of 99.9% and 87.9%, respectively. Etrimfos and Parathion were detected in 75.8% and 64.5% of participants. Four types of OPs—Ethoprophos, Phorate, Diazinon, and Malathion, categorized into ≤LOD and >LOD groups—had detection rates ranging from 20% to 60%. OP exposure was not associated with T2D risk in the overall population. Among participants with baseline FBG ≥ 6.1 mmol/L, OP exposure showed a positive association with incident T2D and with increases in FBG during a 5-year follow-up. In contrast, OP exposure was associated with decreased FBG in the overall population. Moreover, significant interactions were observed between OP exposure and baseline FBG levels (Pinteraction < 0.05), suggesting that baseline glucose levels may modify the metabolic effects of chronic OP exposure. These findings highlight the importance of considering basal glucose status when evaluating the long-term metabolic effects of OP exposure.
No takes yet. Share an insight, caveat, or question.
Yan et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: